文献速递瓣膜外科

血流校正压力阶差在外科主动脉瓣置换术中的临床价值

Clinical value of the flow-adjusted pressure gradient in patients undergoing surgical aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-04-14

本研究基于日本7家机构515例孤立性外科主动脉瓣置换患者,评估血流校正压力阶差(平均压力阶差/每搏输出量)与3年心血管死亡及心衰再住院复合终点的关系。

要点

  • 血流校正压力阶差是外科主动脉瓣置换术后3年不良心脏事件的独立预测因子。
  • 高血流校正压力阶差组(≥0.30 mm Hg/mL)终点发生率显著高于低值组(14.8% vs 5.3%)。
  • 传统平均压力阶差、每搏输出量和患者-人工瓣膜不匹配与终点无显著关联。

核心结论

  • 血流校正压力阶差与孤立性外科主动脉瓣置换术后3年不良心脏事件风险增加相关。
  • 将血流校正压力阶差纳入常规参数可能改善人工瓣膜功能评估。

研究设计与样本

  • 多中心回顾性队列研究,纳入2016年1月至2021年12月日本7家机构734例孤立性外科主动脉瓣置换患者。
  • 排除4例急诊和215例术后超声数据缺失后,最终分析515例。
  • 血流校正压力阶差定义为平均压力阶差除以每搏输出量。
  • 主要终点为3年心血管死亡和心衰再住院的复合终点。

主要发现

  • 中位年龄76岁(IQR 70-80),男性240例(46.6%)。
  • 中位血流校正压力阶差为0.20 mm Hg/mL(IQR 0.15-0.25)。

关键数值与推荐

  • 血流校正压力阶差计算:平均压力阶差除以每搏输出量。
  • 高血流校正压力阶差组界定为≥0.30 mm Hg/mL(n=62,12.0%)。
  • 低血流校正压力阶差组界定为<0.30 mm Hg/mL(n=453,88.0%)。

临床怎么用

  • 在外科主动脉瓣置换术后评估中,可考虑计算血流校正压力阶差以辅助风险分层。
  • 血流校正压力阶差≥0.30 mm Hg/mL的患者可能需更密切随访。

局限性

  • 回顾性研究设计。
  • 排除215例术后超声数据缺失患者可能引入选择偏倚。
  • 高血流校正压力阶差组样本量较小(n=62)。
  • 高/低分组阈值用于探索性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Accurate assessment of prosthetic valve function after surgical aortic valve replacement is still challenging. This study aims to evaluate the clinical utility of the flow-adjusted pressure gradient after surgical aortic valve replacement. METHODS: A total of 734 patients underwent isolated surgical aortic valve replacement at 7 Japanese institutions between January 2016 and December 2021. After excluding 4 emergency cases and 215 cases with missing postoperative echocardiographic data, 515 patients were analyzed. The flow-adjusted pressure gradient was defined as mean pressure gradient divided by stroke volume. The primary end point was a composite of 3-year cardiovascular death and heart failure rehospitalization. RESULTS: The median age was 76 years (interquartile range, 70-80), and 240 patients (46.6%) were male. The median flow-adjusted pressure gradient was 0.20 mm Hg/mL (interquartile range, 0.15-0.25). In univariable analysis, mean pressure gradient, stroke volume, and prosthesis-patient mismatch were not significantly associated with the primary end point (P = .14, .98, and .73, respectively). In multivariable analysis, flow-adjusted pressure gradient remained an independent predictor of the primary end point (adjusted hazard ratio, 1.76; 95% CI, 1.11-2.67; P = .012). Patients were categorized into high (≥0.30 mm Hg/mL; n = 62 [12.0%]) and low (<0.30 mm Hg/mL; n = 453 [88.0%]) flow-adjusted pressure gradient groups for exploratory analysis, and the incidence of the primary end point was significantly higher in the high flow-adjusted pressure gradient group than in the low flow-adjusted pressure gradient group (14.8% vs 5.3%; P = .004). CONCLUSIONS: Flow-adjusted pressure gradient was associated with an increased risk of 3-year adverse cardiac events after isolated surgical aortic valve replacement. Integrating flow-adjusted pressure gradient into conventional parameters may improve the assessment of prosthetic valve function.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ohmori T, Maeda K, Hiraoka A, et al. Clinical value of the flow-adjusted pressure gradient in patients undergoing surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2026. PMID: 41985624. doi:10.1016/j.jtcvs.2026.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。